Trial Profile
A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2015
Price :
$35
*
At a glance
- Drugs Cetirizine (Primary)
- Indications Allergic conjunctivitis
- Focus Pharmacokinetics
- Sponsors Aciex Therapeutics
- 14 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 27 Jun 2014 New trial record